Provided by Tiger Trade Technology Pte. Ltd.

LifeStance Health Group, Inc.

12.28
+0.12000.99%
Post-market: 12.280.00000.00%17:33 EDT
Volume:3.62M
Turnover:44.00M
Market Cap:4.69B
PE:95.31
High:12.30
Open:12.19
Low:11.92
Close:12.16
52wk High:12.97
52wk Low:4.77
Shares:382.06M
Float Shares:249.00M
Volume Ratio:1.31
T/O Rate:1.46%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.1288
EPS(LYR):0.0200
ROE:3.43%
ROA:2.32%
PB:3.18
PE(LYR):614.00

Loading ...

Nov 21, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 07, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2025

Major Issues Report

Form 8-K - Current report
Aug 22, 2025

Major Issues Report

Form 8-K - Current report
Aug 18, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 18, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 18, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 18, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 18, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 18, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 18, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 18, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 07, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 07, 2025

Major Issues Report

Form 8-K - Current report
Jun 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 06, 2025

Major Issues Report

Form 8-K - Current report
Jun 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 14, 2025

Major Issues Report

Form 8-K - Current report
May 07, 2025

Major Issues Report

Form 8-K - Current report
May 07, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]